glp-1 with cv benefit Reducing Risk of Major Adverse Cardiovascular Events: Role of SGLT2 Inhibitors, Agonists Pharmacological treatment for patients with

Brain glutathione levelsa novel biomarker for mild cognitive impairment and Alzheimers disease

Ovid Technologies (Wolters Kluwer Health)

Insulin levels themselves often decline over time, indicating that your cells are becoming more responsive to the hormone your body naturally produces

A randomized, placebo-controlled study in 52 subjects (mean age, 30 years) with relapsing-remitting multiple sclerosis found an increase in total antioxidant capacity in blood with lipoic acid supplementation (1,200 mg/day for 12 weeks) yet not in the activity of specific antioxidant enzymes (superoxide dismutase and glutathione peroxidase) (97)